Skip to content

Research and development of mesoscopic microscopic imaging system for spatial distribution of human tissue metabolic status

Research and development of mesoscopic microscopic imaging system for spatial distribution of human tissue metabolic status

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119722
Enrollment
Unknown
Registered
2026-03-03
Start date
2026-03-03
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Non-tumor group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Samples from our hospital, either from surgical resection or biopsy based on clinical decision-making, yielding residual tissue suitable for research, or from biological samples retained during previous diagnosis and treatment in our hospital; 2.Informed consent from the subjects has been obtained; 3.Complete intraoperative/postoperative pathological reports or biopsy pathological reports are available to confirm the tissue type; 4.The sample meets the laboratory quality control standards; 5.Clinical baseline information can be obtained for correlation analysis;

Exclusion criteria

Exclusion criteria: 1.The subject did not provide or withdrew informed consent, or the scope of sample authorization did not include the use in this study; 2.Significant quality issues arose during the specimen collection process, rendering the specimens unusable for imaging (such as severe damage, contamination, and drying and cracking of the samples); 3.The sample size is insufficient to complete the prescribed 3D imaging process (e.g., the specimen volume is less than the minimum acquisition threshold); 4.The subject has a comorbid serious infectious disease and there are unresolved biosafety hazards in sample processing, which cannot be safely addressed in compliant facilities; 5.The pathological diagnosis is unclear and the tissue type remains undetermined even after review; 6.Other situations that are not suitable for inclusion in this study (such as samples already being used in other research projects that cannot be shared, or legal/ethical restrictions);

Design outcomes

Primary

MeasureTime frame
;

Countries

China

Contacts

Public ContactNie Xiu

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

niexiuyishi@126.com+86 27 8572 6125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026